A Mini Systematic Review: Eucheuma cottonii, a Red Algae, as a Radiosensitizer? doi.org/10.26538/tjnpr/v5i1.2

Main Article Content

Tisa P. Putri
Ida A.T.K. Dewi
Tiara B.M. Permata
Endang Nuryadi
Henry Kodrat
Heri Wibowo
Melva Louisa
Soehartati A. Gondhowiardjo

Abstract

Radiosensitizers assist radiotherapy in providing greater tumor inactivation. Currently there is a search for natural radiosensitizer components which are expected to provide lesser side effects than chemical radiosensitizers. Eucheuma cottonii is a plant with antioxidant and anti-tumor effects. This review aims to search for the potential use of Eucheuma cottonii as a radiosensitizer. This is a mixed review study, where the main component is a systematic review and then followed by a narrative review. This review suggests that Eucheuma cottonii has the potential to become a radiosensitizer, by interfering with the cell cycle control mechanisms and reactivation of p53. Further research is needed to explore the synergistic effect of the combined use of radiotherapy and Eucheuma cottonii

Downloads

Download data is not yet available.

Article Details

How to Cite
Putri, T. P., Dewi, I. A., Permata, T. B., Nuryadi, E., Kodrat, H., Wibowo, H., Louisa, M., & Gondhowiardjo, S. A. (2021). A Mini Systematic Review: Eucheuma cottonii, a Red Algae, as a Radiosensitizer? doi.org/10.26538/tjnpr/v5i1.2. Tropical Journal of Natural Product Research (TJNPR), 5(1), 7-15. https://tjnpr.org/index.php/home/article/view/813
Section
Articles

How to Cite

Putri, T. P., Dewi, I. A., Permata, T. B., Nuryadi, E., Kodrat, H., Wibowo, H., Louisa, M., & Gondhowiardjo, S. A. (2021). A Mini Systematic Review: Eucheuma cottonii, a Red Algae, as a Radiosensitizer? doi.org/10.26538/tjnpr/v5i1.2. Tropical Journal of Natural Product Research (TJNPR), 5(1), 7-15. https://tjnpr.org/index.php/home/article/view/813

References

New Global Cancer Data: GLOBOCAN 2018 | UICC [Internet]. [cited 2020 Nov 3]. Available from: https://www.uicc.org/news/new-global-cancer-dataglobocan-2018

Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, Jemal A, Kramer JL, Siegel RL. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019; 69(5):363-385.

Kuruba V and Gollapalli P. Natural radioprotectors and their impact on cancer drug discovery. Rad Oncol J. 2018;36(4):265-275.

Van Weelden,W.J., Sekarutami,S.M., Bekkers,R.L.M, Kaanders,J.H., Bussink J, Gondhowiardjo SA, Leer,J.W. The Effect of Carbogen Breathing and Nicotinamide Added to Standard (Chemo)Radiation Treatment of Advanced Cervical Cancer in Indonesia. Int J Gynecol Cancer. 2014;24:1628-1635.

Malik A, Sultana M, Qazi A, Qazi MH, Parveen G, Waquar S, Ashraf AB, Rasool M. Role of Natural Radiosensitizers and Cancer Cell Radioresistance : An Update. Anal Cell Pathol. 2016; 2016:1-8.

Liu Z, Gao T, Yang Y, Meng F, Zhan F, Jiang Q, Sun X. Anti-Cancer Activity of Porphyran and Carrageenan from Red Seaweeds. Molecules 2019; 24(23):1-14.

Namvar F, Mohamed S, Ghasemi S, Behravan J. Polyphenolrich seaweed (Eucheuma cottonii) extract suppresses breast tumour via hormone modulation and apoptosis induction. Food Chem. 2012; 130(2):376-82.

Noor A, Gunasekaran S, Vijayalakshmi MA. Article in Pharmacognosy Research · October 2017. Pharmacog Res. 2018; 10:24-30.

Lee JW and Teo SS. In-vitro Cytotoxicity and Anticancer Activity of Eucheuma Cottonii Extracts Against Hela Cell ine. Malay J Sci. 2013; 32:189-196.

Shamsabadi FT, Khoddami A, Shamsabadi FT. Comparison of Tamoxifen with Edible Seaweed (Eucheuma cottonii L)

Extract in Suppressing Breast Tumor. Nutrition and Cancer.2013;65(2):255-262. 11. Chern HT and Vi-Sion Chang SST. Cytotoxic Activity of Eucheuma Cottonii on MCF-7 Human Breast Cancer. Malay J Sci. 2014; 33(2):155-162.

Ying LT, Fenny VD, Sze YCC, Thau LYW. Antiproliferative Potential of Extracts from Kappaphycus Seaweeds on HeLa Cancer Cell Lines. Sains Malaysiana. 2014; 43(12):1895-1900.

Lee JW, Wang JH, Ng KM, Tan-Rabina P, Teo S. In-vitro Anticancer Activity of Eucheuma Cottonii Extracts Againts

Hela Cell Line, HUMN Lung Carcinoma Cell Line (SK-LU-1), Human Colon Carcinoma Cell Line (HCT-116), and Fibroblast. IJCMS. 2015; 1(2):69-73.

Suganya AM, Sanjivkumar M, Chandran MN, Palavesam A, Immanuel G. Pharmacological importance of sulphated polysaccharide carrageenan from red seaweed Kappaphycus alvarezii in comparison with commercial carrageenan.

Biomed Pharmacother. 2016; 84:1300-1312.

Arsianti AA, Fadilah F, Fatmawaty Y, Wibisono LK, Kusmardi S, Azizah NN, Putrianingsih R, Murniasih T, Rasyid A, Pangestuti R. Phytochemical composition and anticancer activity of seaweeds Ulva lactuca and Eucheuma cottonii against breast MCF-7 and colon HCT-116 cells. Asian J Pharm Clin Res. 2016; 9(6):115-9.

Prasedya ES, Miyake M, Kobayashi D, Hazama A. Carrageenan delays cell cycle progression in human cancer

cells in vitro demonstrated by FUCCI imaging. BMC Compl Altern Med. 2016; 16(1):1-9.

Chang VS, Okechukwu PN, Teo SS. The properties of red seaweed (Kappaphycus alvarezii) and its effect on mammary carcinogenesis. Biomed Pharmacother. 2017; 87:296-301.

Bakar N, Tengku IT, Mohamad SN, Mohamed S. Changes in rats’ breast tumor ultrastructure and immune and messenger RNA responses caused by dietary Seaweed (Kappaphycus alvarezii) extract. J Microsc Ultrastruct. 2017; 5(2):70.

Arsianti A, Aziza YAN, Kurniasari KD, Mandasari BKD, Masita R, Zulfa FR, Dewi MK, Zagloel CRZ, Azizah NN, Putrianingsih R. Phytochemical test and cytotoxic activity of macroalgae Eucheuma cottonii against cervical HeLa cells.

Pharmacog J. 2018; 10(5):1012-1017.

Arsianti A, Kurniawan G, Tejaputri NA, Qorina F, Fithrotunnisa Q, Azizah NN, Fajrin AM. Phytochemical Profile, Antioxidant Activity and Cell Line Study of Marine Red Macroalgae Eucheuma cottonii on Lung A-549 Cancer Cells. Pharmacogn J. 2020; 12(2):276-281.

Maier P, Hartmann L, Wenz F, Herskind C. Cellular pathways in response to ionizing radiation and their

targetability for tumor radiosensitization. Int J Mol Sci. 2016; 17(1):102.

Lu M, Breyssens H, Salter V, Zhong S, Hu Y, Baer C, Ratnayaka I, Sullivan A, Brown NR, Endicott J, Knapp S, Kessler BM, Middleton MR, Siebold C, Jones EY, Sviderskaya EV, Cebon J, John T, Caballero OL, Goding CR, Lu X. Restoring p53 Function in Human Melanoma Cells by Inhibiting MDM2 and Cyclin B1/CDK1-Phosphorylated Nuclear iASPP. Cancer Cell. 2013;23(5):618-633.

Mittal R, Jaiswal P, Goel A. Survivin: A molecular biomarker in cancer. Indian J Med Res. 2015; 141:389.

Aveic S, Pigazzi M, Basso G. BAG1: The guardian of antiapoptotic proteins in acute myeloid leukemia. PLoS One. 2011; 6(10):e26907.

Shiao SL, Preethi GA, Rugo HS, Coussens LM. Immune microenvironments in solid tumors: New targets for therapy.

Genes Dev. 2011; 25(24):2559-2572.

Gondhowiardjo SA, Handoko, Adham M, Rachmadi L, Kodrat H, Tobing DL, Haryoga IM, Dwiyono AG, Kristian

YA, Permata TBM. Tumor Microenvironment Predicts Local Tumor Extensivemess in PD-L1 Positive Nasopharingeal Cancer. PLoS ONE. 2020;15(3):1-10.

Gondhowiardjo SA, Handoko, Jayalie VF, Apriantoni R, Barata AR, Senoaji F, Utami IGAAJW, Maubere F, Nuryadi

E, Giselvania A. Tackling Resistence to Cancer Immunotherapy: What Do We Know?. Molecules. 2020;25(18):4096

Smith TD, Tse MJ, Read EL, Liu WF. Regulation of macrophage polarization and plasticity by complex activation signals. Integr Biol (United Kingdom). 2016; 8(9):946-955.

Plewka D, Plewka A, Miskiewicz A, Morek M, Bogunia E. Nuclear factor-kappa B as potential therapeutic target in

human colon cancer. J Cancer Res Ther. 2018; 14(3):516- 520.

Sato H, Niimi A, Yasuhara T, Permata TBM, Hagiwara Y, Isono M, Nuryadi E, Sekine R, Oike T, Kakoti S, Yoshimoto

Y, Held KD, Suzuki Y, Kono K, Miyagawa K, Nakano T, Shibata A. DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells. Nat Commun. 2017; 8(1):1-11.

Buchbinder EI and Desai A. CTLA-4 and PD-1 pathways similarities, differences, and implications of their inhibition.

Am J Clin Oncol Cancer Clin Trials. 2016; 39(1):98-106.